V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300008060 | 300004668 | 1.67 | null | Neo-adjuvant (N) | 2014-02-20 | 2014-02-21 | Capecitabine | 02 | N | 300017290 | OXALIPLATIN + MDG |
| 300008061 | 300004670 | 1.81 | 60 | Palliative (P) | 2014-05-26 | 2014-06-05 | Irinotecan + Modified De Gramont | 02 | N | 300017300 | EOX |
| 300008062 | 300007775 | 1.67 | 65 | Curative (C) | 2014-08-10 | 2014-08-21 | Cetuximab 7 day (>Cycle 2) | N | Y | 300017312 | CAPECITABINE + RT |
| 300008063 | 300004674 | 1.79 | 54.2 | Palliative (P) | 2016-04-13 | 2016-04-13 | Nilotinib | Y | N | 300017327 | PACLITAXEL |
| 300008064 | 300004679 | 1.55 | null | Curative (C) | null | 2013-11-14 | Oxaliplatin + Modified de Gramont | 02 | N | 300017353 | CAPECITABINE |
| 300008065 | 300007777 | 1.6 | 85.85 | Neo-adjuvant (N) | null | 2015-01-25 | TEMOZOLOMIDE | null | N | 300017380 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 300008066 | 300006939 | 1.67 | 76 | Neo-adjuvant (N) | 2019-04-01 | 2019-04-03 | MITOTANE | null | N | 300017397 | TRIAL |
| 300008067 | 300004692 | null | null | null | 2014-11-22 | 2014-11-30 | PEMBROLIZUMAB | N | N | 300017426 | CISPLATIN + FLUOROURACIL |
| 300008068 | 300004697 | 1.73 | 59.75 | Curative (C) | null | 2014-09-08 | Folfirinox | N | N | 300017468 | PACLITAXEL |
| 300008069 | 300004707 | 1.57 | 68.5 | Neo-adjuvant (N) | 2014-10-29 | 2014-11-26 | Trial Unspecified | N | null | 300017511 | HYDROXYCARBAMIDE |
| 300008070 | 300008125 | 1.73 | 80 | null | 2017-07-24 | 2017-07-27 | Cetuximab + Radiotherapy Maint | Y | Y | 300017536 | CETUXIMAB |
| 300008071 | 300004717 | 1.62 | null | Not known (9) | 2016-03-24 | 2016-03-29 | CETUXIMAB + RT | N | Y | 300017581 | CISPLATIN + FLUOROURACIL + RT |
| 300008072 | 300004724 | 1.59 | 60.3 | Curative (C) | 2015-09-18 | 2015-09-23 | Carboplatin AUC 6 - 10 | N | null | 300017655 | ESPAC TRIAL |
| 300008073 | 300004727 | 1.71 | null | Palliative (P) | 2017-03-05 | 2017-04-05 | PACLITAXEL | N | null | 300017661 | CAPECITABINE |
| 300008074 | 300004729 | 1.67 | 93.6 | Curative (C) | 2014-07-01 | 2014-07-01 | Pemetrexed | 02 | null | 300017685 | DE-ESCALATE TRIAL |
| 300008075 | 300004733 | null | 54 | Neo-adjuvant (N) | 2014-01-18 | 2014-01-18 | FLUOROURACIL + OXALIPLATIN | 2 | N | 300017710 | TRIAL |
| 300008076 | 300004737 | 1.57 | 52.3 | Palliative (P) | 2016-12-28 | 2017-01-21 | Carboplatin AUC 2 - 5 | 02 | N | 300017727 | BENDAMUSTINE |
| 300008077 | 300004739 | 2 | 90.5 | Palliative (P) | 2016-08-29 | 2016-10-21 | GemCarbo Days 1+8 | N | N | 300017751 | CAPECITABINE |
| 300008078 | 300004742 | 1.61 | 75 | null | 2015-12-06 | 2015-12-18 | GemCarbo Days 1+8 | N | N | 300017758 | CAPECITABINE + CARBOPLATIN |
| 300008079 | 300004752 | 1.51 | null | Curative (C) | null | 2017-11-29 | Gemcitabine + Oxaliplatin | 02 | null | 300017826 | CAPECITABINE + GEMCITABINE |
| 300008080 | 300004754 | 1.67 | 96 | Curative (C) | 2016-06-29 | 2016-07-18 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300017829 | TRIAL |
| 300008081 | 300006969 | 1.49 | 40 | Neo-adjuvant (N) | 2013-09-13 | 2013-09-13 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | Y | 300017857 | CAPECITABINE + RT |
| 300008082 | 300004765 | null | 63 | Curative (C) | 2017-02-07 | 2017-03-19 | Folfirinox | 02 | N | 300017888 | OXALIPLATIN + MDG |
| 300008083 | 300004767 | 1.6 | 84.5 | Palliative (P) | 2017-01-19 | 2017-01-20 | CAPECITABINE + CARBOPLATIN + Cetuximab | N | N | 300017894 | OXALIPLATIN + MDG |
| 300008084 | 300004769 | 1.58 | 74 | Adjuvant (A) | 2014-06-25 | 2014-07-04 | Cetuximab 7 day (>Cycle 2) | 02 | Y | 300017904 | CISPLATIN + FLUOROURACIL |
| 300008085 | 300004779 | 1.84 | 58.6 | Palliative (P) | 2015-07-07 | 2016-02-26 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | Y | N | 300017947 | TRIAL |
| 300008086 | 300007797 | 1.78 | 56 | Palliative (P) | null | 2017-08-30 | Trial Unspecified | N | null | 300017954 | CARBOPLATIN |
| 300008087 | 300004799 | 1.62 | 76.8 | Neo-adjuvant (N) | 2016-06-05 | 2016-06-15 | Folfirinox | N | N | 300022313 | CETUXIMAB |
| 300008088 | 300004804 | 1.65 | 0 | null | 2016-02-02 | 2016-05-08 | Trial Unspecified | 02 | N | 300022340 | DOCETAXEL |
| 300008089 | 300004811 | 1.49 | 58.7 | Adjuvant (A) | 2016-06-30 | 2016-11-02 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 300022410 | IRINOTECAN + MDG |
| 300008090 | 300004827 | null | null | Radical (R) | 2014-09-03 | 2014-09-25 | IMATINIB | N | null | 300022505 | TRIAL |
| 300008093 | 300004838 | 1.6 | 65.4 | Palliative (P) | 2017-02-06 | 2017-10-01 | NAB PACLITAXEL | Y | N | 300022645 | HYDROXYCARBAMIDE |
| 300008094 | 300004847 | 1.77 | 85.4 | Curative (C) | 2017-05-13 | 2017-09-17 | Cetuximab 7 day (>Cycle 2) | 2 | Y | 300022711 | CARBOPLATIN + RT |
| 300008095 | 300004850 | null | 73.5 | Palliative (P) | 2016-02-06 | 2016-08-13 | CAV | N | null | 300022727 | GEMCITABINE + OXALIPLATIN |
| 300008096 | 300004853 | 1.67 | 90.6 | Curative (C) | 2017-07-15 | 2017-09-16 | Carbo F | null | null | 300022737 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300008097 | 300004858 | 1.6 | 101.7 | Curative (C) | 2015-03-22 | 2015-04-12 | CARBOPLATIN + RT | N | Y | 300022846 | DE-ESCALATE TRIAL |
| 300008099 | 300004866 | 1.58 | 108 | Disease modification (D) | 2018-05-05 | 2018-05-05 | Cisplatin +Fluorouracil (3 wk) | 2 | N | 300022967 | CAPECITABINE |
| 300008100 | 300004872 | 1.76 | 65 | Curative (C) | null | 2016-07-29 | Ipilimumab | null | null | 300023002 | CETUXIMAB |
| 300008101 | 300007815 | 1.59 | 57 | Neo-adjuvant (N) | 2016-08-29 | 2016-10-24 | Folfirinox | N | N | 300023068 | CARBOPLATIN + ETOPOSIDE |
| 300008102 | 300004880 | 1.64 | 57 | Adjuvant (A) | 2015-03-18 | 2015-03-27 | EOX | null | N | 300023187 | CAPECITABINE + CARBOPLATIN |
| 300008103 | 300004888 | 1.81 | 63.2 | Curative (C) | 2014-09-26 | 2014-12-23 | Paclitaxel (2 or 3 weekly) | 02 | null | 300023270 | FLUOROURACIL + MITOMYCIN |
| 300008104 | 300004902 | 1.74 | null | Curative (C) | 2017-06-15 | 2017-08-09 | CARBOPLATIN + CETUXIMAB + FU | null | Y | 300023483 | CAPECITABINE + CISPLATIN + RT |
| 300008105 | 300004919 | null | 74.7 | Neo-adjuvant (N) | null | 2016-04-07 | CISPLATIN + FLUOROURACIL | N | null | 300023703 | OXALIPLATIN |
| 300008106 | 300004920 | null | 90.3 | Adjuvant (A) | 2015-02-18 | 2015-02-27 | Folfirinox | 02 | N | 300023705 | CAPECITABINE + OXALIPLATIN |
| 300008107 | 300004926 | 1.77 | 90 | Disease modification (D) | 2018-05-02 | 2018-06-14 | Bortezomib + Cyclophos + Dex | 2 | N | 300023894 | OXALIPLATIN + MDG |
| 300008108 | 300004929 | null | null | null | 2017-02-01 | 2017-02-05 | Cetuximab + Radiotherapy Maint | N | Y | 300023919 | CAPECITABINE + RT |
| 300008109 | 300004931 | 1.64 | 59 | Palliative (P) | 2017-06-30 | 2017-07-05 | Oxaliplatin + Modified de Gramont | 01 | N | 300023934 | CAPECITABINE |
| 300008110 | 300004936 | 1.62 | 77.2 | Curative (C) | 2013-12-23 | 2013-12-30 | Hydroxycarbamide | 2 | null | 300023954 | CETUXIMAB |
| 300008111 | 300004951 | null | 54.8 | Curative (C) | 2014-04-05 | 2014-04-08 | CETUXIMAB | 2 | null | 300024228 | FEC |
| 300008112 | 300004959 | 1.51 | 117 | Curative (C) | 2014-04-29 | 2014-06-10 | Cisplatin | N | Y | 300024331 | CISPLATIN |